Helen Brough

Biography

Helen Brough is a consultant in Pediatric Allergy and Immunology at the Evelina Children’s Hospital, St. Thomas’ Hospital and professor of Pediatric Allergy at King’s College London University.

She co-leads the transition and joint allergy respiratory service at the Children’s Allergy Service, Evelina Children’s Hospital, St. Thomas’ Hospital and was the Head of Service from 2015 to 2023.

Helen is the medical advisor for the Natasha Allergy Research Foundation and is on the Health Advisory Board for the Patient Advocacy charity Allergy UK. She was the President of the Royal Society of Medicine Allergy and Immunology Section from 2022-2024. She was the Chair/Past Chair of the European Academy of Allergy and Clinical Immunology (EAACI) Pediatric Section from 2019-2022.

She also runs a private allergy service as the founder and director of Children’s Allergy Doctors, which specializing in eczema, food allergy prevention and desensitization (oral immunotherapy), allergic rhinitis management and hayfever desensitisation and asthma.

She was awarded the ‘Health Professional of the Year’ runner-up by Coeliac UK in 2010, the Barry Kay award from the British Society for Allergy and Clinical Immunology (BSACI) in 2013, and the Distinguished Clinician Award by the American Academy of Asthma, Allergy, and Immunology (AAAAI) in 2020.

Helen's research interests are in food allergy prevention and management. She is a principal investigator for the Stopping Eczema and Allergy (SEAL) study assessing whether proactive skin care in young infants with dry skin or eczema prevents the development of food allergy, the Pronuts study evaluating selective nut eating in nut allergic children, and the Global Assessment of Psychology Services for Food Allergy (GAPS) study. She was a co-investigator on several peanut oral and patch immunotherapy trials. She co-authored the European guidelines for the management of atopic eczema, and the food allergy prevention studies Learning Early About Peanut (LEAP, LEAP-ON, LEAP-Trio) and Enquiring About Tolerance (EAT) study.